Minerva Neurosciences (NERV) Other Gross PP&E Adjustments (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Other Gross PP&E Adjustments readings, the most recent being -$8.9 million for Q4 2021.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 6.88% to -$8.9 million in Q4 2021 year-over-year; TTM through Jun 2021 was -$364861.0, a 16.6% increase, with the full-year FY2021 number at -$8.9 million, up 6.88% from a year prior.
  • Other Gross PP&E Adjustments hit -$8.9 million in Q4 2021 for Minerva Neurosciences, down from -$227874.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$209514.0 in Q3 2020 to a low of -$9.6 million in Q4 2020.
  • Median Other Gross PP&E Adjustments over the past 3 years was -$437486.0 (2020), compared with a mean of -$3.1 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: dropped 23.49% in 2020 and later skyrocketed 47.47% in 2021.
  • Minerva Neurosciences' Other Gross PP&E Adjustments stood at -$7.8 million in 2019, then decreased by 23.49% to -$9.6 million in 2020, then rose by 6.88% to -$8.9 million in 2021.
  • The last three reported values for Other Gross PP&E Adjustments were -$8.9 million (Q4 2021), -$227874.0 (Q3 2021), and -$364861.0 (Q2 2021) per Business Quant data.